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EVery High Perforation Rate in
Patients Undergoing Unsuccessful
Percutaneous Coronary
Interventions of Chronic Total
Occlusions Could Explain Worse
Outcome in These Patients and
Not Chronically Occluded Artery
In the paper by Mehran et al. (1), the authors concluded that
failure to open chronic total occlusion (CTO) lesions leads to a
higher rate of cardiac death, total death, and coronary artery bypass
surgery (CABG). The authors explain their findings on the basis of
the possible deleterious effects of a persistently closed artery
leading to more adverse events. However, the authors did not
comment on the procedural complications, such as perforations,
that could have occurred during a long, complicated CTO procedure,
such as renal failure, bleeding, or peripheral vascular injury. In this
registry, patients with unsuccessful CTO percutaneous coronary
intervention had a high rate of procedural-related coronary perfora-
tion (7.4% vs. 1.7% in the successfully treated arm). The authors did
not mention the rate of death or urgent CABG occurring among
those with coronary perforation and whether this might explain the
higher frequency of CABG, mortality, and myocardial infarction
occurring in the unsuccessful CTO intervention cohort.
Let us compare this study to a hypothetical randomized clinical
trial where any complication (including death or perforation)
would be assigned to the treatment group independent of success-
ful delivery of the treatment (i.e., an intention-to-treat analysis).
Applying this rule to the current study and transferring the
perforation rate of 7.5% in the unsuccessful CTO intervention arm
(higher than the 5.8% cardiac mortality in the failed CTO arm
after 5 years) to the arm with successful CTO intervention would
clearly show that overall CTO intervention led to a relatively poor
outcome. Therefore, their conclusion should have been that
intervention of CTO lesions would have been harmful due to the
very high procedural complication rate, offsetting any potential
benefit. Multivariate analysis adjusting for perforation would be
invalid, because perforation was related to intervention and not due
to a permanently occluded artery that was blamed for the poor
long-term outcome. Other important percutaneous coronary
intervention-related complications, such as contrast-induced ne-
phropathy and bleeding, were not mentioned. Lee et al. (2) published
their experience with regard to unsuccessful CTO intervention in the
same month that this current report was published. In the Lee et al.
(2) paper, they showed no difference in any outcomes between
uccessful or unsuccessful CTO intervention, despite worse baseline
haracteristics of patients undergoing unsuccessful CTO attempt,
hereby somewhat contradicting the current paper.Mohammad Reza Movahed, MD, PhD
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Chronic Total Occlusion
Recanalization
A Call for a Randomized Trial
Mehran et al. (1) recently reported the results of a multicenter
observational study examining long-term outcomes of 1,791 pa-
tients after percutaneous coronary intervention (PCI) for chronic
total occlusion (CTO) lesions, comparing the patients who suc-
ceeded in the procedure with those who failed. The authors report
an overall procedural success rate of 68% and detected in their
model that a successful CTO procedure was an independent
predictor of reduced cardiac mortality with a strong trend toward
lower all-cause mortality. Although the authors should be congrat-
ulated for reporting on such a large cohort of patients undergoing PCI
to CTO lesions, we found the analysis biased against the patients who
failed PCI. Furthermore, there are several methodological deficiencies
in the study that significantly impair the power of this study and put
into question the accuracy of their conclusion.
To address the question of whether treating CTO by PCI
impacts on late clinical events, the control group should have
appropriately included patients assigned to medical therapy and
not those who failed PCI. Comparing the treatment effect of a
device between a group that succeeded in a procedure and another
that failed might directly lead to a major bias and does not offer any
meaningful conclusion other than the intuitive fact that when the
procedure fails it is bad for the patient.
Second, the authors also reported that the rate of coronary artery
bypass graft procedures for the failed PCI group was higher in
patients whose occlusions could not be opened (13.3% vs. 3.2%,
p  0.01), leading to an impression that such an event is more
frequent when the attempt to open a difficult CTO has failed;
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117however, it might be related to vascular injuries that were more
frequent in patients with failed PCI, such as coronary perforation
(7.4% vs. 1.7%, p  0.01) and residual dissection (9.4% vs. 4.3%,
p  0.01), thereby exaggerating the relative benefits of a
successful opening of the occluded artery. Consistent with that,
our group previously reported analysis of a cohort of patients
with failed but uncomplicated CTO PCI procedures, showing
similar rates of death and myocardial infarction at a mean
follow-up of 2 years (2). It would be appropriate to repeat the
analysis of the authors and compare the successful PCI group
with the noncomplicated failed group and examine whether
their conclusion still holds.
Finally, with regard to the use of drug-eluting stents (DES)
versus bare-metal stents (BMS), the authors reported that treat-
ment with DES in comparison with BMS resulted in similar
definite/probable stent thrombosis rates (1.7% vs. 2.3%, p 0.58);
owever, only 4.2% of patients in the DES group versus 42% of the
atients in the BMS group reached 5-year follow-up. This major
ifference in follow-up time could lead to a bias as well.
We agree that performing a randomized clinical trial comparing
CI for CTO and conservative therapy with medications only,
uch as in the upcoming DECISION-CTO (Drug-Eluting Stent
mplantation vs. Optimal Medical Treatment in Patients with
hronic Total Occlusion) trial, might reveal whether treating
hese complex lesions has an effect on clinical result.
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Reply
We thank Dr. Movahed and Dr. Badr and colleagues for their
expressed interest in our study. Dr. Movahed refers to the potential
implications of the relatively high perforation rate observed in our
study (1). In our study, the definition we employed for coronary
perforation included any one of the 3 types proposed by Ellis et al.
(2). However, the specific type of perforation was not recorded. A
recent Bayesian meta-analysis by Shimony et al. (3) showed thatmorbidity and mortality after coronary perforation vary directly
with the Ellis classification. Mortality was 0.3%, 0.4%, and 21.2%
after type I, II, and III perforations, respectively, clearly indicating
that not every type of perforation is associated with catastrophic
outcomes.
In our study, 30-day mortality in patients with a coronary perfo-
ration was 0%, and 1-year mortality was 5.2%. Therefore, it is highly
unlikely that a significant number of type III perforations occurred.
Finally, the performance of coronary artery bypass surgery was not
within an urgent time frame, but within months of the failed
percutaneous coronary intervention (PCI) procedure, therefore re-
flecting the decision to proceed with complete revascularization at a
later point. Because of the low mortality rate after coronary perfora-
tion, we do not agree with the suggestion that chronic total occlusion
(CTO) PCI overall is associated with a poor outcome.
Nonetheless, we do acknowledge the fact that despite favorable
outcomes, the rate of this complication was high. Operators perform-
ing CTO intervention should make every effort to minimize this
potentially hazardous complication and should inform the patient of
the risk of a coronary perforation during the informed consent
process. Moreover, future randomized clinical trials investigating the
potential benefit of CTO PCI should carefully record the incidence,
types, and outcomes of coronary artery perforation.
Regarding the comments by Dr. Badr and colleagues, we agree that
our study is limited by its observational nature and by the fact that the
control group does not include patients assigned to medical therapy.
Nonetheless, as our control group consisted of patients with CTO
lesions that were deemed suitable for PCI, the applicability of the
study results extends beyond the mere intuitive fact that when a
procedure fails, it is bad for the patient. In the absence of randomized
controlled trials investigating the effect of PCI of CTOs compared
with medical therapy, we cannot exclude that part of the observed
worse outcome in the failed PCI group in our study may be attributed
to harmful effects of a failed procedure. The other part may be
attributed to a beneficial effect of a successful procedure.
Finally, we agree wholeheartedly that the results of well-designed
randomized controlled trials investigating a potential benefit of CTO
PCI, such as EXPLORE (Evaluating Xience V and Left Ventricular
Function in Percutaneous Coronary Intervention on Occlusions
after ST-Elevation Myocardial Infarction) (4), DECISION-CTO
(Drug-Eluting Stent Implantation vs. Optimal Medical Treat-
ment in Patients with Chronic Total Occlusion), and the EURO-
CTO (European Study on the Utilization of Revascularization vs.
Optimal Medical Therapy for the Treatment of Chronic Total
Coronary Occlusions) are eagerly awaited. Long-term follow-up of
these studies will also provide further insight into the safety and
efficacy of (newer-generation) drug-eluting stents in CTO lesions.
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